CANF logo

CANF CapEx to Revenue

Current (TTM)0.49%
CANF CapEx/Revenue (4.05% → 0.49%)
High-resolution chart · PNG

CANF capex to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Can-Fite Biopharma Ltd American Depositary Shares, each representing two (2) Ordinary Shares CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
0.4941%
0.7418%
0.2692%
1.1111%
1.2896%
3.4076%
0.1476%
0.8639%
0.8174%
6.135%
27.5273%
0%
0%
0%
4.5378%
4.0469%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.